Alector (ALEC) Other Non-Current Assets (2018 - 2026)
Alector (ALEC) reported Other Non-Current Assets of $369000.0 for Q1 2026, down 80.01% year-over-year from $1.8 million in Q1 2025, and down 4.4% quarter-over-quarter from $386000.0 in Q4 2025.
Alector (ALEC) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Other Non-Current Assets data on file, last reported at $369000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $369000.0, down 80.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $369000.0 (down 80.01% YoY), and the FY2025 annual result was $386000.0, up 28.67% from the prior year.
- Other Non-Current Assets fell to $369000.0 in Q1 2026 per ALEC's latest filing, from $386000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $7.4 million in Q4 2023 and troughed at $300000.0 in Q4 2024.
- A 5-year average of $2.2 million and a median of $1.5 million in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets sank 95.96% in 2024, then jumped 190.69% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $6.4 million in 2022, then rose by 15.74% to $7.4 million in 2023, then slumped by 95.96% to $300000.0 in 2024, then rose by 28.67% to $386000.0 in 2025, then declined by 4.4% to $369000.0 in 2026.
- Business Quant data shows ALEC's Other Non-Current Assets at $369000.0 in Q1 2026, $386000.0 in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 369,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 369,000.00 |
| Dec 31, 2025 | 386,000.00 |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 7.42 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 6.41 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 5.57 Mn |
| Sep 30, 2021 | 1.47 Mn |
| Jun 30, 2021 | 1.47 Mn |